Maxcyte (MXCT) Acquisitions (2025)

Maxcyte's (MXCT) quarterly Acquisitions came in at $1.8 million in Q1 2025.

Maxcyte (MXCT) Acquisitions (2025) Analysis & Trends

Maxcyte (MXCT) has 1 years of Acquisitions data on file, last reported at $1.8 million in Q1 2025.

  • On a quarterly basis, Acquisitions changed N/A year-over-year to $1.8 million in Q1 2025; TTM through Dec 2025 was $1.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.8 million, changed N/A from the prior year.
  • Acquisitions for Q1 2025 stood at $1.8 million.
  • Over the last five years, Acquisitions for MXCT reached as high as $1.8 million in Q1 2025 and fell as low as $1.8 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 183.54 Bn 176.24 Bn 6.27 Bn -
2 Stryker 129.03 Bn 126.15 Bn 3.81 Bn 22.00 Mn
3 Medtronic 108.43 Bn 99.21 Bn 6.41 Bn 406.00 Mn
4 Boston Scientific 68.74 Bn 67.28 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 48.34 Bn 44.67 Bn 1.29 Bn -
6 Dexcom 28.35 Bn 27.24 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.07 Bn 25.78 Bn 1.98 Bn 2.30 Bn
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn -268.10 Mn
10 Maxcyte 109.55 Mn 109.55 Mn 8.08 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.77 Mn